Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma. Although the presence of p53 gene mutations has been considered as a bad prognostic feature in DLBCL, its clinical significance is still controversial. the aims of this study were: detect the presence of mutations in exons 5 to 9 of the p53 gene and correlate it to prognosis in DLBCL. Fifty-one DLBCL patients were enrolled in this study. Expression of p53 was evaluated by immunohistochemistry. the screening of p53 mutations was performed using PCR-SSCP methods. Cases showing a mobility shift on SSCP electrophoresis were analyzed by automatic sequencing. We could identify 8 missense mutations in 6 of 48 cases (12.5%). in addition, we found a known polymo...
Background: This study was conducted to analyze the frequency, expression patterns, and the impact o...
grantor: University of TorontoThe most common genetic changes in human tumors are mutation...
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma in adults. We evaluated the immuno...
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma. It has heterogeneous clin...
The prognostic role of TP53 disruption has been established in diffuse large B-cell lymphoma (DLBCL)...
Objective: to reveal the clinical significance of the mutation status of the TP53 gene in the group ...
Abstract Background The knowledge about specific mechanisms generating TP53 dysfunction in diffuse l...
TP53 mutation is an independent marker of poor prognosis in patients with diffuse large B-cell lymph...
The purpose of this study is to correlate the presence of TP53 gene mutations with the clinical outc...
The presence of TP53 mutations has been associated with inferior outcome in diffuse large B-cell lym...
Background. the presence of functionally significant intron mutations in the TP53 gene was demonstra...
BackgroundTP53 dysfunction is implicated in lymphomagenesis and disease progression. Information abo...
TP53 dysfunction is implicated in lymphomagenesis and disease progression. Information about the fre...
p53 mutations are found in a wide variety of cancers, including hematologic malignancies. These alte...
Refractory/relapsed diffuse large B-cell lymphoma (DLBCL) is associated with poor outcome. The clini...
Background: This study was conducted to analyze the frequency, expression patterns, and the impact o...
grantor: University of TorontoThe most common genetic changes in human tumors are mutation...
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma in adults. We evaluated the immuno...
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma. It has heterogeneous clin...
The prognostic role of TP53 disruption has been established in diffuse large B-cell lymphoma (DLBCL)...
Objective: to reveal the clinical significance of the mutation status of the TP53 gene in the group ...
Abstract Background The knowledge about specific mechanisms generating TP53 dysfunction in diffuse l...
TP53 mutation is an independent marker of poor prognosis in patients with diffuse large B-cell lymph...
The purpose of this study is to correlate the presence of TP53 gene mutations with the clinical outc...
The presence of TP53 mutations has been associated with inferior outcome in diffuse large B-cell lym...
Background. the presence of functionally significant intron mutations in the TP53 gene was demonstra...
BackgroundTP53 dysfunction is implicated in lymphomagenesis and disease progression. Information abo...
TP53 dysfunction is implicated in lymphomagenesis and disease progression. Information about the fre...
p53 mutations are found in a wide variety of cancers, including hematologic malignancies. These alte...
Refractory/relapsed diffuse large B-cell lymphoma (DLBCL) is associated with poor outcome. The clini...
Background: This study was conducted to analyze the frequency, expression patterns, and the impact o...
grantor: University of TorontoThe most common genetic changes in human tumors are mutation...
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma in adults. We evaluated the immuno...